Tate & Lyle Ingredients Americas LLC says a clinical trial that shows allulose does not operate as a sugar and lead to tooth decay is another reason why FDA should exempt the low-calorie sweetener from being included as a carbohydrate, sugar or added sugar on the Nutrition Facts label.
You are here: Home / News / Tate & Lyle submits allulose clinical trial in support of FDA labeling petition — Food Chemical News